Citation tools
"Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After 90Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity." Journal of Nuclear Medicine
63.6
(2022):
882-889.
Web. 28 May. 2025.